Understanding the Role of the WTO in Regulating Global Trade

Every time a smartphone assembled in one country reaches a buyer in another, or a generic medicine made in India is shipped abroad, an invisible rulebook is at work. That rulebook is largely written and enforced by the World Trade Organisation (WTO), the only global body that sets the legal ground rules for trade between nations. With over 160 member countries accounting for the vast majority of world trade, the WTO shapes what gets traded, at what cost, and under what conditions. Understanding how it works, and why it remains deeply controversial, is essential to making sense of the modern global economy.

Origins of the WTO: from GATT to a global trade body 🔗

The WTO did not appear out of nowhere. It grew out of a much older arrangement called the General Agreement on Tariffs and Trade (GATT). After the Second World War, governments wanted to avoid the protectionist trade barriers that had worsened the Great Depression. They planned to create an International Trade Organization (ITO) alongside the IMF and the World Bank as a pillar of post-war economic recovery.

That plan stumbled. The ITO charter was agreed in Havana in 1948, but the United States Congress refused to ratify it, and the organisation never came into being. What survived was GATT, a treaty negotiated by 23 countries in Geneva in 1947 that came into force on 1 January 1948. Although it was meant to be temporary, GATT ended up being the only major instrument governing world trade for nearly half a century.

Over those decades, GATT worked through a series of “rounds” of negotiations. Each round brought down tariffs and gradually expanded the rules. By the time GATT was replaced, 125 nations were signatories governing about 90 percent of world trade. But the system had limits. It dealt mainly with goods, its dispute settlement was weak, and countries could pick and choose which side agreements to accept.

The Uruguay Round and the birth of the WTO 🔗

The turning point was the Uruguay Round, which ran from 1986 to 1994 and was the most ambitious set of trade negotiations in GATT’s history. It slashed industrial tariffs, brought agriculture and services into the rulebook, and created a permanent institution to oversee it all. The WTO formally began operations on 1 January 1995, following the Marrakesh Agreement.

The shift was not just a change of name. GATT was a set of rules agreed between nations; the WTO is a full intergovernmental organisation with its own headquarters in Geneva, a permanent staff, and a binding dispute settlement system. Crucially, the WTO adopted a “single undertaking” approach, meaning members must accept the entire rulebook rather than selectively opting out of inconvenient parts. Where GATT dealt mainly with trade in goods, the WTO also covers services and intellectual property.

Core principles of the WTO 🔗

At the heart of the WTO sits a small set of principles that all the agreements share. They are designed to make trade more predictable and to stop powerful countries from rigging the system in their own favour. The most important of these is non-discrimination, which takes two forms.

Most-favoured-nation treatment 🔗

The most-favoured-nation (MFN) principle sounds like it grants special privileges, but it actually means the opposite. Under MFN, a country cannot normally play favourites among its trading partners. If a member lowers a customs duty for one country’s product, it must extend the same treatment to all other WTO members. This rule is so fundamental that it appears as the very first article of GATT. The effect is that every member is treated as a “most favoured” partner, which prevents discriminatory blocs and exclusive clubs.

National treatment 🔗

The second pillar is national treatment. Once a foreign product, service, or piece of intellectual property has entered the local market, it must be treated no less favourably than equivalent domestic products. In simple terms, the MFN rule stops a country discriminating between other countries, while national treatment stops it discriminating against other countries in favour of its own. Both principles run through all the major WTO agreements, including GATT 1994, the services agreement (GATS), and the intellectual property agreement (TRIPs).

Free trade, predictability and fair competition 🔗

Beyond non-discrimination, the WTO is built on the idea of progressively freer trade through negotiation, gradually lowering barriers like tariffs and import quotas. It also stresses predictability: when a country agrees to a tariff ceiling, that commitment becomes binding and enforceable, so businesses can plan with confidence. A further principle is transparency, requiring members to make their trade rules clear and open. Together these principles are meant to create a level playing field where competition is based on quality and price rather than political muscle.

WTO agreements and TRIPs 🔗

The WTO is really a bundle of agreements rather than a single document. Among the most consequential, and the most contested, is the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPs). This agreement requires every member country to adopt and enforce minimum standards of intellectual property protection, covering patents, copyrights, trademarks, and more.

TRIPs effectively pushed countries to bring their patent laws into line with those of the United States, Europe, and Japan. A patent gives its holder exclusive rights over an invention, typically for 20 years, after which the invention enters the public domain. While this rewards innovation, it also creates monopolies that can keep prices high during the protection period. Nowhere has this tension been felt more sharply than in the pharmaceutical sector.

TRIPs and the Indian patent system 🔗

India offers the clearest illustration of why TRIPs matters. The Patents Act of 1970 had deliberately excluded product patents on medicines, recognising only process patents. This allowed Indian companies to legally reverse-engineer patented drugs and produce cheaper generic versions, building what became one of the world’s largest generic medicine industries and earning the country its reputation as the “pharmacy of the developing world”.

TRIPs changed this. As a WTO member, India was obliged to recognise product patents. It amended the Patents Act in three stages in 1999, 2002, and 2005, with the 2005 amendment replacing the process patent regime with a product patent system. The transition period gave the industry roughly a decade to prepare. Many feared this would cripple the generic sector and push medicine prices out of reach.

The balancing act: public health and flexibilities 🔗

The reality turned out to be more nuanced. The TRIPs framework includes flexibilities such as compulsory licensing, which lets a government authorise production of a patented drug without the patent holder’s consent in certain circumstances. The Doha Declaration on TRIPs and Public Health in 2001 reaffirmed that the agreement should be read in a way that protects public health and promotes access to medicines.

India built strong public-health safeguards into its law. A famous example is the provision against “evergreening”, where companies make minor changes to existing drugs to extend monopolies. This provision was upheld when the Supreme Court ruled against Novartis in 2013. Interestingly, rather than collapsing, the Indian pharmaceutical industry adapted, increasing its research and development investment and expanding into global value chains. TRIPs shows how a single WTO agreement can reshape entire industries and force difficult trade-offs between rewarding innovation and protecting the right to affordable healthcare.

Challenges and criticisms of the WTO 🔗

For all its reach, the WTO faces serious criticism, particularly from developing nations. The central complaint is that the system, despite its language of equality, tends to favour wealthy and powerful members.

Unequal decision-making power 🔗

On paper, the WTO operates by consensus, giving every member an effective say. In practice, critics argue, many important decisions are shaped in informal “green room” negotiations involving a handful of powerful economies, while poorer countries struggle to participate fully. Developing countries often lack the resources and technical expertise to engage with every facet of complex negotiations, which limits their ability to influence the agenda-setting and deliberation process. The result, opponents say, is a structure that is far less democratic than its one-country-one-vote image suggests.

The Doha Round deadlock 🔗

These tensions came to a head in the Doha Development Round, launched in 2001 with a promise to put developing countries at the centre of trade reform. Liberalising agricultural trade, especially cutting the heavy farm subsidies of rich countries, was meant to be the heart of the agenda. Years of negotiations followed, marked by collapses such as the 2003 Cancun ministerial, where developing nations led by India and Brazil refused to accept deals they saw as one-sided.

The Doha Round has never been concluded, and its failure underscores the limitations of the WTO’s current framework. Many analysts argue that although the WTO succeeded in lowering tariffs, the benefits to developing countries have been muted, and the organisation has struggled to address deeper structural inequalities in the global trading system.

Fairness, subsidies, and the dispute system 🔗

Another long-running grievance concerns agricultural subsidies. Wealthy economies in North America and Europe continue to support their farmers heavily, which critics say undercuts farmers in developing countries who cannot compete with artificially cheap imports. At the same time, the WTO’s once-powerful dispute settlement system has itself fallen into crisis. The United States blocked the appointment of new Appellate Body members, effectively paralysing the body that hears trade appeals and leaving a key part of the enforcement machinery in limbo. These overlapping problems have led some observers to question whether the WTO can adapt to a world of trade wars, digital commerce, and renewed protectionism.

What do you think? If the WTO’s principle of equal treatment so often produces unequal outcomes, should the rules be redesigned to give weaker economies genuine bargaining power, or is a flawed global trade body still better than none at all? And when a single agreement like TRIPs can decide whether life-saving medicines stay affordable, where should the line be drawn between protecting innovation and protecting public health?

References

1. https://www.wto.org/english/thewto_e/whatis_e/tif_e/fact4_e.htm
2. https://www.britannica.com/topic/General-Agreement-on-Tariffs-and-Trade
3. https://www.britannica.com/topic/World-Trade-Organization
4. https://www.wto.org/english/thewto_e/history_e/history_e.htm
5. https://www.wto.org/english/thewto_e/whatis_e/tif_e/fact2_e.htm
6. https://www.cambridge.org/core/books/abs/law-and-policy-of-the-world-trade-organization/principles-of-nondiscrimination/2D5B5EC0DF14BD9BE4C20F5BDD820F95
7. https://pmc.ncbi.nlm.nih.gov/articles/PMC12934350/
8. https://www.lawctopus.com/academike/impact-of-trips-on-pharmaceutical-industry/
9. https://www.cfr.org/backgrounders/whats-next-wto
10. https://ili.ac.in/pdf/paper5.pdf
11. https://journals.sagepub.com/doi/10.1177/0260107919875573
12. https://www.wto.org/english/forums_e/ngo_e/posp67_gaddafi_found_e.pdf
13. https://archive-yaleglobal.yale.edu/node/44641
14. https://www.joams.com/2025/JOAMS-V13N2-41.pdf